Physician profile
Aveed Samiee
NPI 1912287384
$683.90
in general payments reported to CMS, 2019-2025
10 companies · $21.72 in 2025
The $21.72 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $16.48 · 2022: $70.92 · 2023: $177 · 2025: $21.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orapharma, A Division of Bausch Health US, LLC | $140.88 | 2019-2025 | Arestin |
| Zimmer Biomet Holdings, INC. | $124.90 | 2019 | |
| Straumann USA LLC | $117.49 | 2023 | |
| Implant Direct Sybron International LLC | $95.40 | 2019 | |
| Ormco Corporation | $58.33 | 2022 | |
| Henry Schein, INC. | $55.00 | 2019 | |
| Dentsply Sirona INC | $38.27 | 2023 | Suresmile, Tph Spectra Universal Composite Restorative Low Viscosity |
| Voco America INC. | $21.04 | 2023 | Viscalor Bulk, Admira Fusion, Futurabond U |
| Nobel Biocare USA | $20.00 | 2019 | |
| Ultradent Products INC | $12.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aveed Samiee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.